Compare Ginkgo Bioworks Holdings Inc (DNA) vs Kraft Heinz Co (KHC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Ginkgo Bioworks Holdings Inc vs Kraft Heinz Co — how do they compare? Ginkgo Bioworks Holdings Inc trades at $7.51 (market cap $505.73M), while Kraft Heinz Co trades at $24.65 (market cap $29.23B). The key difference: Kraft Heinz Co is far larger — about 57.8× Ginkgo Bioworks Holdings Inc's market cap, and Kraft Heinz Co pays a 6.49% dividend while Ginkgo Bioworks Holdings Inc pays none. Which is the better fit depends on your goals.
| DNA | KHC | |
|---|---|---|
Market Cap | $505.73M | $29.23B |
Sector | Health | Consumer Staples |
52-Week High | $16.14 | $28.06 |
52-Week Low | $5.48 | $21.21 |
Enterprise Value | $607.68M | $45.55B |
Dividend Yield | — | 6.49% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Ginkgo Bioworks Holdings Inc
Ginkgo Bioworks is a leading horizontal platform for cell programming. It uses advanced automation and software to design custom organisms for customers across diverse industries, including food, agriculture, and pharma.
Read more on DNA →About Kraft Heinz Co
In July 2015, Kraft merged with Heinz to create the third-largest food and beverage manufacturer in North America behind PepsiCo and Nestle and the fifth-largest player in the world. Beyond its namesake brands, the combined firm's portfolio includes Oscar Mayer, Velveeta, and Philadelphia. Outside North America, the firm's global reach includes a distribution network in Europe and emerging markets that drive around one fifth of its consolidated sales base, as its products are sold in more than 190 countries and territories.
Read more on KHC →
